ViralGains, Inc., today announced that VG Health, its advertising solution built for pharma and healthcare marketers, has won the Fierce AI Innovation Award for “AI Innovation in Programmatic Marketing”, recognizing its ability to help pharmaceutical brands improve commercialization outcomes through more precise patient reach, engagement and media optimization. Presented by Fierce, a leading healthcare media organization, the Fierce AI Innovation Awards recognize companies moving beyond AI pilots to deliver measurable impact across biotech, pharma and healthcare.
“We are honored to be recognized by Fierce and proud of the measurable success our customers are achieving with VG Health,” said Tod Loofbourrow, CEO of ViralGains. “By helping pharma and healthcare marketers better understand where patients are in their journey, we can drive better outcomes, from finding undiagnosed patients and reducing wasted media to moving more people toward appropriate care.”
Healthcare and pharmaceutical marketers are facing growing expectations to improve commercialization outcomes by delivering more precise, relevant patient outreach while maintaining strict privacy standards. Built specifically for this industry, VG Health enables brands to uncover high-value patient segments, understand their needs, increase media efficiency, and deliver educational content that resonates without depending on personally identifiable information.
The approach is delivering measurable results. Demand for VG Health has grown more than 6x over the past two years, while campaigns have achieved up to 3x higher audience quality versus partner benchmarks, 35% more efficient cost per patient reached, 34% more new patient starts, 26% more doctor visits, and 66% more total prescriptions.
Traditional programmatic targeting can identify broad patient categories, but often misses critical context such as treatment satisfaction, disease severity, medication awareness and intent to seek care. VG Health addresses this gap with privacy-friendly Zero-Party Ads that capture voluntary, real-time patient feedback. VoiceAlike® AI combines these signals with traditional targeting and healthcare data to build campaign-specific predictive audiences, personalize messaging and suppress low-relevance impressions across channels, including CTV. Because each model continuously learns from campaign signals, marketers can refine targeting and media delivery throughout the campaign to reach the right patients with messaging relevant to where they are in their healthcare journey.
The Fierce recognition marks VG Health’s second major industry award in 2026, following its selection as AdTech Privacy Solution of the Year in the MarTech Breakthrough Awards. The honors reflect growing demand for AI-powered healthcare marketing solutions built on higher-quality, privacy-friendly signals.
ViralGains is a marketing platform that helps brands and agencies better discover, understand and nurture customers by leveraging the power of zero-party data in ads through creative interactivity and audience-building AI solutions. Its award-winning VG Health solution helps pharmaceutical and healthcare brands better understand patient and HCP audiences, improve media efficiency, and drive measurable commercialization outcomes. Headquartered in Boston, with locations in New York, Chicago, and San Francisco, the company powers results for the most successful digital marketers and advertisers, including over 100 of the Fortune 500, nearly half of the Fortune 100, and half of the Fortune 10. For more information, please visit https://www.viralgains.com.